EC Gastroenterology and Digestive System

Gastroenterologists must look up from our area of work and consider stomatological conditions, as they cause numerous gastrointestinal pathological processes and vice versa.

In this work we address the intimate relationships that exist between the oral and intestinal microbiome and how both influence one on the other, the other on one.

Clinical data are presented, so as not to forget to investigate and visualize them, in order to determine the strategies to follow, both from the point of view of the traditional laboratory and of omics studies.

Oraloma is considered, as well as gastrointestinal conditions, related, between the two most important microbiota, the intestinal and the oral.

Finally, we evaluate what can serve to improve both microbiota, for the benefit of the health of patients.

 Keywords: Oral Microbiota (OM); Dysbiosis (D); Oral dysbiosis (OD); Microbiome (M)

1. Stašková A., et al. “Oral microbiota from the stomatology perspective”. Bacterial Biofilms (2020): 2-23.
2. Deo PN and Deshmukh R. “Oral microbiome: Unveiling the fundamentals”. Journal of Oral and Maxillofacial Pathology 1 (2019): 122-128.
3. Willis JR and Gabaldón T. “The human oral microbiome in health and disease: from sequences to ecosystems”. Microorganisms2 (2020): 308.
4. Li X., et al. “The oral microbiota: Community composition, influencing factors, pathogenesis, and interventions”. Frontiers in Microbiology 13 (2022): 895537.
5. Daley TD and Armstrong JE. “Oral manifestations of gastrointestinal diseases”. Canadian Journal of Gastroenterology and Hepatology 21 (2007): 952673.
6. Sinead Harty., et al. “A prospective study of the oral manifestations of Crohn’s disease”. Clinical Gastroenterology and Hepatology9 (2005): 886-891.
7. Li Chunyu., et al. “Oral manifestations serve as potential signs of ulcerative colitis: A review”. Frontiers in Immunology 13 (2022): 1013900.
8. Rashid M., et al. “Oral manifestations of celiac disease: a clinical guide for dentists”. Journal of the Canadian Dental Association 77 (2011): b39.
9. Jukka H Meurman., et al. “Oral and dental manifestations in gastroesophageal reflux disease”. Oral Surgery, Oral Medicine, Oral Pathology5 (1994): 583-589.
10. Reitano E., et al. “Oral bacterial microbiota in digestive cancer patients: a systematic review”. Microorganisms12 (2021): 2585.
11. Abraham Hirshberg., et al. “Metastatic tumours to the oral cavity - Pathogenesis and analysis of 673 cases”. Oral Oncology8 (2008): 743-752.
12. Cancino J., et al. “Manejo estomatológico del paciente con Hepatopatías: una revisión de la literatura [Stomatological management of patients with liver disease: a review of the literature]”. Revista Científica Odontológica (Lima)2 (2023): e153.
13. P Maisonneuve., et al. “Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis”. Annals of Oncology5 (2017): 985-995.
14. Jajam M., et al. “Oral manifestations of gastrointestinal disorders”. Journal of Clinical and Experimental Dentistry 10 (2017): e1242-e1248.
15. Willis JR and Gabaldón T. “The human oral microbiome in health and disease: from sequences to ecosystems”. Microorganisms2 (2020): 308.
16. Elzayat H., et al. “Unraveling the impact of gut and oral microbiome on gut health in inflammatory bowel diseases”. Nutrients15 (2023): 3377.
17. Radaic A and Kapila YL. “The oralome and its dysbiosis: New insights into oral microbiome-host interactions”. Computational and Structural Biotechnology Journal 19 (2021): 1335-1360.
18. Newman KL and Kamada N. “Pathogenic associations between oral and gastrointestinal diseases”. Trends in Molecular Medicine 12 (2022): 1030-1039.
19. Chen J., et al. “The correlation between oral colonization of Helicobacter pylori and gastrointestinal disease”. Journal of Stomatology4 (2011): 351-354.
20. Li S., et al. “Helicobacter pylori infection is correlated with the incidence of erosive oral lichen planus and the alteration of the oral microbiome composition”. BMC Microbiology 1 (2021): 122.
21. Xun Z., et al. “Dysbiosis and ecotypes of the salivary microbiome associated with inflammatory bowel diseases and the assistance in diagnosis of diseases and the assistance in diagnosis of diseases using oral bacterial profiles”. Frontiers in Microbiology 9 (2018): 1136.
22. John Nsor-Atindana., et al. “The resilience of nanocrystalline cellulose viscosity to simulated digestive processes and its influence on glucose diffusion”. Carbohydrate Polymers 200 (2018): 436-445.
23. Rosier BT., et al. “Resilience of the oral microbiota in health: mechanisms that prevent dysbiosis”. Journal of Dental Research4 (2018): 371-380.
24. Tran VTA., et al. “Oral pathogenic bacteria-inducing neurodegenerative microgliosis in human neural cell platform”. International Journal of Molecular Sciences 13 (2021): 6925.
25. Se-Young Park., et al. “Oral-gut microbiome axis in gastrointestinal disease and cancer”. Cancers9 (2021): 2124.
26. Mortensen P Brøbech and M Rye Clausen. “Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease”. Scandinavian Journal of Gastroenterology 216 (1996): 132-148.
27. Guan X., et al. “A double-edged sword: Role of butyrate in oral cavity and the gut”. Molecular Oral Microbiology2 (2020): 121-131.
28. Leonov GE., et al. “The complicated relationship of short-chain fatty acids and oral microbiome: a narrative review”. Biomedicines10 (2023): 2749.
29. Beikler T., et al. “Oral microbiota transplant in dogs with naturally occurring periodontitis”. Journal of Dental Research7 (2021): 764-770.
30. Nascimento M. “Oral microbiota transplant: a potential new therapy for oral diseases”. Journal of the California Dental Association10 (2017): 565-568.
31. Kaźmierczyk-Winciorek M., et al. “The immunomodulating role of probiotics in the prevention and treatment of oral diseases”. Central European Journal of Immunology 1 (2021): 99-104.
32. Benjamin Bartsch., et al. “The role of dietary supplements, including biotics, glutamine, polyunsaturated fatty acids and polyphenols, in reducing gastrointestinal side effects in patients undergoing pelvic radiotherapy: A systematic review and meta-analysis”. Clinical and Translational Radiation Oncology 29 (2021): 11-19.